Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 399, 739-740 (24 June 1999) | doi:10.1038/21550
Open Innovation Challenges
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
nature jobs
Group Leader Positions
- The International Iberian Nanotechnology Laboratory (INL)
- Braga Portugal
Group Leader Positions
- IMP
- Vienna Austria
Alzheimer's disease: Pinning down phosphorylated tau
Michel Goedert1
A defining characteristic of several neurodegenerative diseases, including Alzheimer's disease and Pick's disease, is the formation of filamentous deposits of a microtubule-associated protein called tau in an abnormally hyperphosphorylated form. The discovery of mutations in the tau gene in a condition known as 'familial frontotemporal dementia and parkinsonism linked to chromosome 17' has renewed interest in the mechanisms by which dysfunction of tau causes neurodegeneration.
- Michel Goedert is at the MRC Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, UK.
e-mail: Email: mg@mrc-lmb.cam.ac.uk
To read this story in full you will need to login or make a payment (see right).

